by Sara M. Nolte | Apr 18, 2023
One of the major limitations of using stem cell donors is the challenge of finding an adequate match, which is why I always get excited about therapies that use a patient’s own tissue. But why is the issue of a “match” such a big deal? You may have come across terms...
by Cal Strode | Mar 29, 2023
Few people have made bigger contributions to the Canadian regenerative medicine ecosystem than Dr. Peter Zandstra. He is co-founder of two companies advancing cutting-edge biotechnologies for therapeutic use (Notch Therapeutics and ExCellThera, both of which are...
by Stacey Johnson | Feb 17, 2023
In 2019 I wrote an open letter to Joe Rogan, asking him to be more judicious in how he discusses stem cells on his popular – 12.8 million subscribers – podcast, The Joe Rogan Experience. Much to my surprise, I didn’t hear back from Joe or his people although I tagged...
by Sara M. Nolte | Jan 19, 2023
While you all know me as a writer for Signals, I actually spend most of time working clinically. When wearing my health-care provider hat as a physician assistant in orthopaedics, I’m often asked about the use of stem cell therapy for the treatment of arthritis....
by CCRM Australia | Dec 6, 2022
Bhavi Kadakia was an intern with CCRM Australia in 2020 and is currently employed at Novotech. In the health-care sector, translation and commercialization have traditionally been described as complex and requiring heavy investment. As such, it is imperative for...
Comments